Management of hypertensive crises: the scientific basis for treatment decisions

The spectrum of disorders associated with an elevated blood pressure (BP) encompasses chronic uncomplicated hypertension and the hypertensive crises, including hypertensive urgencies and emergencies. Although these syndromes vary widely in their presentations, clinical courses, and outcomes they sha...

Full description

Saved in:
Bibliographic Details
Published in:American Journal of Hypertension 2001-11, Vol.14 (11), p.1154-1167
Main Authors: Blumenfeld, Jon D, Laragh, John H
Format: Article
Language:English
Subjects:
Administration, Oral
Algorithms
Antihypertensive agents
Antihypertensive Agents - administration & dosage
Antihypertensive Agents - therapeutic use
Aortic Aneurysm - complications
Biological and medical sciences
Cardiovascular system
Eclampsia - complications
Female
Heart Failure - complications
Humans
Hypertension - drug therapy
Hypertension - etiology
Hypertension, Malignant - complications
Hypertensive Encephalopathy - complications
Injections, Intravenous
Intracranial Hemorrhage, Hypertensive - complications
Male
Medical sciences
Pharmacology. Drug treatments
Pregnancy
Pulmonary Edema - complications
Stroke - complications
Treatment Outcome
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The spectrum of disorders associated with an elevated blood pressure (BP) encompasses chronic uncomplicated hypertension and the hypertensive crises, including hypertensive urgencies and emergencies. Although these syndromes vary widely in their presentations, clinical courses, and outcomes they share pathophysiologic mechanisms and, consequently, therapeutic responses to specifically targeted antihypertensive drug types. Nevertheless, hypertensive crises are often treated with drugs which, in that setting are either unsafe or are of unsubstantiated efficacy. The purpose of this review is to examine the pathophysiology of commonly encountered hypertensive crises, including stroke, hypertensive encephalopathy, aortic dissection, acute pulmonary edema, and preeclampsia-eclampsia and to provide a rational approach to their treatment based upon relevant pathophysiologic and pharmacologic principles. Measurement of plasma renin activity (PRA) level often provides insight regarding pathophysiology and predicts efficacy of antihypertensive treatments in the individual patient. However, in hypertensive crises, drug therapy is initiated before the PRA level is known. Nevertheless, the renin-angiotensin dependence (R-type) or volume dependence (V-type) of hypertension can often be deduced by the BP response to drugs that interrupt the renin system (R-drugs) or that decrease body volume (V-drugs). Based upon these considerations, a treatment algorithm is provided to guide drug selection in patients presenting with a hypertensive crisis.
ISSN:0895-7061
1879-1905
1941-7225
DOI:10.1016/S0895-7061(01)02245-2